×
AllImagesNewsShopping Maps Videos Books
Search tools

News about Vertex

Vertex stem cell therapy spurs insulin independence

STAT · 2 days ago

Vertex’s Cell Therapy Could Be ‘Functional Cure’ for Diabetes, but Market Prospects Uncertain

BioSpace · 2 days ago

Vertex Pharmaceuticals Presents “Unprecedented” Data for T1D Cell Therapy Zimislecel, Shows Durable Benefit

Yahoo Finance · 1 day ago

Vertex's remaining islet cell therapy reduces dangerously low blood sugar levels in phase 1/2 test

Fierce Biotech · 3 days ago

Vertex Pharma’s Type 1 Diabetes Cell Therapy Shows Potential to Achieve Insulin Independence

MedCity News
A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional...
2 days ago

Cautious Hold Rating for Vertex Pharmaceuticals Amid Limited Uptake and Insurance Challenges for Journavx

TipRanks
Terence Flynn, an analyst from Morgan Stanley, maintained the Hold rating on Vertex Pharmaceuticals (VRTX – Research Report).
23 hours ago

Vertex presents data from Phase I/II stage of trial for type 1 diabetes

Clinical Trials Arena
Vertex Pharmaceuticals has shared data from the Phase I/II segment of the Phase I/II/III FORWARD-101 trial, evaluating zimislecel for T1D.
2 days ago

ADA: Vertex closer to weaning type 1 diabetics off insulin

pharmaphorum
A cell therapy developed by Vertex Pharma has allowed 10 of 12 patients with type 1 diabetes to control their blood sugar without insulin.
1 day ago

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions

Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase...
5 days ago

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Ono Pharmaceutical Co., Ltd. (OTCMKTS: OPHLY) today announced an exclusive...
3 days ago